Frequency of dyslipidaemia among patients of lichen planus presenting to tertiary care setting
DOI:
https://doi.org/10.66344/jpad.34.1.2024.2451Keywords:
Frequency, lichen planusAbstract
Background Lichen planus (LP) is a chronic inflammatory disorder that affects skin and/or mucous membranes. It is a T-cell-mediated inflammatory disorder which causes lipid metabolic aberrations and is associated with increased risk of cardiovascular diseases.  Objective To assess the prevalence of dyslipidemia in patients of lichen planus which presents to the Dermatology Department at a tertiary care setting.  Methods In this cross sectional survey, 80 cases of lichen planus were included after clinical and histopathological confirmation. Presence or absence of dyslipidemia was confirmed by fasting lipid profile. Patients taking lipid lowering drugs, patients of diabetes, hypothyroidism (TSH >4.2mIU/ml), hypertension or ischemic heart disease, patients with BMI more than 30 kg/m2, patients with family history of dyslipidemia and early cardiac death, were excluded. Stratification of dyslipidemia with regards to age, gender and area of involvement was carried out.  Results There were 47 (58.8%) males and 33 (41.2%) females. Mean age of the patients was 39.00±11.76 years. Cutaneous lichen planus was seen in 32 (40%) patients, mucosal in 28 (35%) patients and both (cutaneous and mucosal) in 20 (25%) patients. Dyslipidemia was present in 48 (60%) patients. Stratification of dyslipidemia with regard to age and gender was not significant but with regard to mucosal and cutaneous involvement it was significant.  Conclusion Lichen planus is significantly related to dyslipidemia according to this study. Therefore meticulous screening for dyslipidemia is needed in patients of LP. ÂReferences
Tziotzios C, Lee J.Y.W, Brier T, Saito R, Hsu C.K, Bhargava K, Stefanato C.M, Fenton D.A, McGrath J.A. Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis. J Am Acad Dermatol. 2018;79(5):789–804.
Okpala I.C, Akinboro A.O, Ezejoifor I.O, Onunu A.N, Okwara B.U. Metabolic Syndrome and Dyslipidemia among Nigerians with Lichen Planus: A Cross-Sectional Study. Indian J Dermatol. 2019;64(4):303–10.
González-Moles M.Ã, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Ã, Lenouvel D, Ruiz-Ãvila I, Ramos-GarcÃa P. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2021;27(4):813–28.
Özkur E, U˘gurer E, Altunay I.K. Dyslipidemia in Lichen Planus: A Case-control Study. Med Bull Sisli Etfal Hastan Tip Bul. 2020;54(1):62–6.
Husein-ElAhmed H, Gieler U, Steinhoff M. Lichen planus: A comprehensive evidence-based analysis of medical treatment. J Eur Acad Dermatol Venereol. 2019;33(10):1847–62.
Saleh N, Samir N, Megahed H, Farid E. Homocysteine and other cardiovascular risk factors in patients with lichen planus. J Eur Acad Dermatol Venereol. 2014; 28(11):1507-13.
Singla R, Ashwini P.K, Jayadev B. Lichen Planus and Metabolic Syndrome: Is There a Relation? Indian Dermatol Online J. 2019;10(5):555–9.
Hashba H, Bifi J, Thyvalappil A, Sridharan R, Sreenivasan A, Mathew P. Prevalence of Metabolic Syndrome in Patients with Lichen Planus: A Cross-sectional Study from a Tertiary Care Center. Indian Dermatol Online J. 2018;9(5):304–8.
Hasan S, Ahmed S, Kiran R, Panigrahi R, Thachil J.M, Saeed S. Oral lichen planus and associated comorbidities: An approach to holistic health. J Fam Med Prim Care. 2019;8(3):3504–17.
Dreiher J, Shapiro J, Cohen AD. Lichen planus and dyslipidaemia: A case‑control study. Br J Dermatol. 2009;161:626‑9.
López‑Jornet P, Camacho‑Alonso F, RodrÃguez‑MartÃnes MA. Alterations in serum lipid profile patterns in oral lichen planus: A cross‑sectional study. Am J Clin Dermatol. 2012;13:399‑404.
Gupta S, Gupta S. Alterations in serum lipid profile patterns in oral cancer and oral precancerous lesions and conditions – A clinical study. Indian J Dent. 2011;2:1‑7.
Arshad Z , Sanai M, Nusrat W, Asghar MN, Ghias A, Arshad A.Frequency of dyslipidemia in patients with lichen planus. J Pak Assoc Dermatol. 2021;31(4):643-6.
Khan S, Pirzado MS, Kalhoro HBA, Rajper N, Memon SM, Memon FH. Frequency of Dyslipidemia in Patients with Lichen Planus: A Comparative Cross-Sectional Study. J Liaquat Uni Med Health Sci. 2022;21(02):121-5.
Azeez N, Asokan N. Association of lichen planus with dyslipidemia: A comparative, cross-sectional study. Clin Dermatol Rev. 2019;3:68-71.
Nasiri S, Sadeghzadeh-Bazargan A, Robati RM, Haghighatkhah HR, Younespour S. subclinical atherosclerosis and cardiovascular markers in patients with lichen planus: A case-control study. Indian J Dermatol Venerol Leprol. 2019;85:138-44.
Kumar SA, Krishnam Raju PV, Gopal KVT, Rao TN. Comorbidities in Lichen Planus: A Case-control Study in Indian Patients. Indian Dermatol Online J. 2019;10(1):34-7.
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
